New Dawn Bio
Develops technology to grow wood from tree stem cells in bioreactors for alternative timber and biomaterials production.
Overview
New Dawn Bio is a Dutch deep tech startup developing a process to grow wood from tree stem cells in bioreactors. Its work targets timber and biomaterials markets seeking production methods that do not rely solely on conventional forestry. The company’s differentiator is its cell-based approach to wood cultivation, applying bioreactor systems to plant stem cells. New Dawn Bio raised about €2 million in a pre-seed round to advance development and scale its wood-growing technology.
Funding History
Dutch startup New Dawn Bio raises €2.1 million to grow wood from tree stem cells in bioreactors
Frequently Asked Questions
- How much funding does AI Funding track for New Dawn Bio?
- AI Funding tracks €2M for New Dawn Bio across 1 funding round in this database.
- Who are New Dawn Bio's investors?
- New Dawn Bio's investors include CapitalT, Norrsken Evolve, Ontdekkers Group, Jelle Prins.
- What does New Dawn Bio do?
- New Dawn Bio is a Dutch deep tech startup developing a process to grow wood from tree stem cells in bioreactors. Its work targets timber and biomaterials markets seeking production methods that do not rely solely on conventional forestry. The company’s differentiator is its cell-based approach to wood cultivation, applying bioreactor systems to plant stem cells. New Dawn Bio raised about €2 million in a pre-seed round to advance development and scale its wood-growing technology.
- Where is New Dawn Bio headquartered?
- New Dawn Bio is headquartered in San Francisco, CA.
Investors
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.